Esoterix Inc
Project ID
105094
Facility Name
Esoterix Inc
Analyte
risankizumab drug assay (DRISEC)
Method
electrochemiluminescent immunoassay
Specimen Type
plasma: EDTA/Na heparin; serum
Permit Category
Ther. Sub. Mon./Quant. Tox.
Status
Conditionally Approved
Facility State
CA
Facility ID
3072